← Open Payments lookup

KELLY LOCK: Open Payments

NPI 1003828575 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$687 in 25 payments from 10 companies in 2025. Trend: 2023 $22 · 2024 $0 · 2025 $687

Food & beverage: $687
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$167
GlaxoSmithKline, LLC.6$121
Octapharma USA, Inc.1$92
ARS Pharmaceuticals Operations, Inc.4$77
Regeneron Healthcare Solutions, Inc.2$63
Takeda Pharmaceuticals U.S.A., Inc.3$62
Amgen Inc.2$35
Ionis Pharmaceuticals, Inc.1$25
Novartis Pharmaceuticals Corporation1$24
Genentech USA, Inc.1$22

Products named: TEZSPIRE, TRELEGY ELLIPTA, CUTAQUIG, NEFFY, DUPIXENT, TAKHZYRO, Xolair, AIRSUPRA.

Industry payments across TX — which companies pay providers there.